이소트레티노인 의약품 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 5.5%의 CAGR로 16억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 인지도 증가와 스킨케어 트렌드, 신흥 시장에서의 확대, 여드름 발생률 증가, 인구 고령화, 정신건강 및 웰빙에 대한 관심 증가에 기인하는 것으로 추정됩니다. 예측 기간 동안 주요 동향으로는 연구개발, 기술 발전, 제네릭 의약품의 혁신, 제형 개선, 피부과학의 발전 등을 들 수 있습니다.
피부암 환자의 증가는 향후 이소트레티노인 의약품 시장의 성장을 견인할 것으로 예상됩니다. 피부암은 비정상적인 피부 세포가 통제할 수 없을 정도로 증식하여 발생하며, 대부분 태양이나 선탠 베드에서 나오는 자외선(UV)에 장시간 노출될 때 발생합니다. 피부암 발병률의 증가는 자외선 노출 증가, 오존층 파괴, 충분한 자외선 차단제 없이 야외에서 활동하는 라이프스타일의 변화로 인해 발생합니다. 이소트레티노인 의약품은 비정상적인 피부 세포의 증식을 억제하여 특정 피부암을 예방하고 치료하는 데 사용됩니다. 예를 들어, 미국 암 협회는 2024년 1월에 보고될 피부암 환자 수가 108,270건으로 2023년 보고된 104,930건보다 3.2% 증가할 것으로 예측하고 있습니다. 따라서 피부암 유병률의 증가는 이소트레티노인 의약품 시장을 견인할 것으로 보입니다.
이소트레티노인 제제 시장의 주요 업체들은 치료 옵션을 늘리고 환자의 접근성을 높이기 위해 이소트레티노인 캡슐과 같은 고급 제제 개발에 주력하고 있습니다. 이 캡슐은 일반적으로 결절성 여드름이나 낭포성 여드름과 같은 심각한 여드름 증상에 처방되며, 심각한 부작용, 특히 선천성 기형의 위험이 높기 때문에 엄격한 사용 가이드라인이 정해져 있습니다. 예를 들어, 2023년 7월, 미국에 본사를 둔 제약회사 Upsher-Smith Laboratories, LLC는 10mg, 20mg, 30mg, 40mg 용량으로 출시된 최초의 이소트레티노인 캡슐 USP를 출시했으며, 이 캡슐은 Accutane과 치료적 동등성(TE 코드 AB1)이 있습니다. TE 코드 AB1)입니다. 이 약은 심한 여드름 치료에 권장되며, 어려운 여드름에 대한 확실한 해결책을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 이소트레티노인 의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 이소트레티노인 의약품 시장 : 성장률 분석
- 세계의 이소트레티노인 의약품 시장 실적 : 규모와 성장, 2019-2024
- 세계의 이소트레티노인 의약품 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 이소트레티노인 의약품 전체 시장(TAM)
제6장 시장 세분화
- 세계의 이소트레티노인 의약품 시장 : 형태별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 캡슐
- 주사
- 세계의 이소트레티노인 의약품 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 중증 여드름
- 신경아세포종
- 피부 T세포 림프종
- 할리퀸 상피증
- 색소성 건피증
- 진행성 골화성 섬유이형성증
- 편평 상피 세포 피부암
- 기타 적응증 종류
- 세계의 이소트레티노인 의약품 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 이소트레티노인 의약품 시장, 캡슐 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 소프트젤 캡슐
- 하드 젤 캡슐
- 액체 충전 캡슐
- 세계의 이소트레티노인 의약품 시장, 주사 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 정맥주사
- 근육내 주사
제7장 지역별·국가별 분석
- 세계의 이소트레티노인 의약품 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 이소트레티노인 의약품 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 이소트레티노인 의약품 시장 : 경쟁 구도
- 이소트레티노인 의약품 시장 : 기업 개요
- F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Hetero Drugs Ltd.
- Sun Pharmaceuticals Industries Limited
- Intas Pharmaceuticals Ltd.
- Aurobindo Pharma
- Dr. Reddy's Laboratories Ltd.
- Cipla Limited
- Amneal Pharmaceuticals LLC
- Lupin Pharmaceuticals Inc.
- Zydus Lifesciences Limited
- Glenmark Pharmaceuticals
- Alkem Laboratories
- Torrent Pharmaceuticals Ltd
- Almirall LLC
- Alembic Pharmaceuticals Ltd
- Ajanta Pharma Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 이소트레티노인 의약품 시장 2029 : 새로운 기회를 제공하는 국가
- 이소트레티노인 의약품 시장 2029 : 새로운 기회를 제공하는 부문
- 이소트레티노인 의약품 시장 2029 : 성장 전략
제36장 부록
ksm
Isotretinoin is a potent medication derived from vitamin A, primarily used to treat severe acne, often leading to significant improvement in skin conditions. It works by reducing oil production and promoting skin renewal, resulting in clearer and healthier skin for many individuals. Typically prescribed when other treatments have failed, it requires strict medical supervision and careful consideration of potential risks and benefits.
The main types of isotretinoin drugs include capsules and injections. Isotretinoin capsules are oral medications that reduce natural oil production in the skin, prevent clogged pores, and help treat and prevent acne. These drugs are indicated for conditions such as severe acne, neuroblastoma, cutaneous T-cell lymphoma, harlequin ichthyosis, Xeroderma pigmentosum, fibrodysplasia ossificans progressiva, squamous cell skin cancers, and others. They are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.
The isotretinoin drugs market research report is one of a series of new reports from the business research company that provides isotretinoin drugs market statistics, including isotretinoin drugs industry global market size, regional shares, competitors with an isotretinoin drugs market share, detailed isotretinoin drugs market segments, market trends and opportunities, and any further data you may need to thrive in the isotretinoin drugs industry. This isotretinoin drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The isotretinoin drugs market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the prevalence of severe acne, the effectiveness of isotretinoin, marketing and awareness campaigns, regulatory approvals, and increased dermatology visits.
The isotretinoin drugs market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growing awareness and skincare trends, expansion in emerging markets, increasing incidence of acne, aging population, and focus on mental health and well-being. Major trends in the forecast period include research and development, technological advancements, generic drug innovations, improved formulations, and advances in dermatology.
The growth in skin cancer cases is expected to drive the expansion of the isotretinoin drugs market in the future. Skin cancer results from the uncontrolled growth of abnormal skin cells, often caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. The increasing incidence of skin cancer can be attributed to greater UV radiation exposure, depletion of the ozone layer, and lifestyle changes leading to more outdoor activities without sufficient sun protection. Isotretinoin drugs are used to prevent and treat certain types of skin cancer by reducing the proliferation of abnormal skin cells. For example, the American Cancer Society projects that there will be 108,270 reported cases of skin cancer in January 2024, representing a 3.2% increase from the 104,930 cases reported in 2023. Hence, the rising prevalence of skin cancer is set to boost the isotretinoin drugs market.
Major players in the isotretinoin drug market are focusing on developing advanced formulations, such as isotretinoin capsules, to improve treatment options and broaden patient accessibility. These capsules are typically prescribed for severe acne conditions, such as nodular or cystic acne, and come with strict usage guidelines due to their significant side effects, especially the high risk of birth defects. For example, in July 2023, Upsher-Smith Laboratories, LLC, a pharmaceutical company based in the US, introduced the first Isotretinoin Capsules USP. Available in 10 mg, 20 mg, 30 mg, and 40 mg doses, these capsules are therapeutically equivalent (TE code AB1) to the brand Accutane. This medication is recommended for treating severe acne, providing a reliable solution for challenging cases.
In January 2024, CHEPLAPHARM Arzneimittel GmbH, a Germany-based pharmaceutical company, acquired Roaccutane from F. Hoffmann-La Roche Ltd. for an undisclosed sum. This acquisition bolsters CHEPLAPHARM Group's dermatological portfolio by securing global rights to Roaccutane, a well-established retinoid medication used to treat severe acne and as a therapeutic option worldwide. F. Hoffmann-La Roche Ltd. is a Switzerland-based healthcare company that manufactures isotretinoin drugs such as Roaccutane.
Major companies operating in the isotretinoin drugs market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Hetero Drugs Ltd., Sun Pharmaceuticals Industries Limited, Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc, Zydus Lifesciences Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd, Almirall LLC, Alembic Pharmaceuticals Ltd, Ajanta Pharma Ltd, Strides Pharma Science Limited, Wockhardt Ltd., Douglas Pharmaceuticals Limited, Chongqing Huapont Pharm Co. Ltd., Cipher Pharmaceuticals Inc., Vidhyasha Pharmaceuticals
North America was the largest region in the isotretinoin drugs market in 2024. The regions covered in the isotretinoin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the isotretinoin drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The isotretinoin drugs market consists of sales of softgels, tablets, and ointments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Isotretinoin Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on isotretinoin drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for isotretinoin drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isotretinoin drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Form: Capsules; Injection
- 2) By Indication Type: Severe Acne; Neuroblastoma; Cutaneous T-Cell Lymphoma; Harlequin Ichthyosis; Xeroderma Pigmentosum; Fibrodysplasia Ossificans Progressiva; Squamous Cell Skin Cancers; Other Indication Types
- 3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Capsules: Soft Gel Capsules; Hard Gel Capsules; Liquid-Filled Capsules
- 2) By Injection: Intravenous Injection; Intramuscular Injection
- Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Bausch Health Companies Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Isotretinoin Drugs Market Characteristics
3. Isotretinoin Drugs Market Trends And Strategies
4. Isotretinoin Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Isotretinoin Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Isotretinoin Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Isotretinoin Drugs Market Growth Rate Analysis
- 5.4. Global Isotretinoin Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Isotretinoin Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Isotretinoin Drugs Total Addressable Market (TAM)
6. Isotretinoin Drugs Market Segmentation
- 6.1. Global Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Capsules
- Injection
- 6.2. Global Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Severe Acne
- Neuroblastoma
- Cutaneous T-Cell Lymphoma
- Harlequin Ichthyosis
- Xeroderma Pigmentosum
- Fibrodysplasia Ossificans Progressiva
- Squamous Cell Skin Cancers
- Other Indication Types
- 6.3. Global Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.4. Global Isotretinoin Drugs Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Soft Gel Capsules
- Hard Gel Capsules
- Liquid-Filled Capsules
- 6.5. Global Isotretinoin Drugs Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intravenous Injection
- Intramuscular Injection
7. Isotretinoin Drugs Market Regional And Country Analysis
- 7.1. Global Isotretinoin Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Isotretinoin Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Isotretinoin Drugs Market
- 8.1. Asia-Pacific Isotretinoin Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Isotretinoin Drugs Market
- 9.1. China Isotretinoin Drugs Market Overview
- 9.2. China Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Isotretinoin Drugs Market
- 10.1. India Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Isotretinoin Drugs Market
- 11.1. Japan Isotretinoin Drugs Market Overview
- 11.2. Japan Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Isotretinoin Drugs Market
- 12.1. Australia Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Isotretinoin Drugs Market
- 13.1. Indonesia Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Isotretinoin Drugs Market
- 14.1. South Korea Isotretinoin Drugs Market Overview
- 14.2. South Korea Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Isotretinoin Drugs Market
- 15.1. Western Europe Isotretinoin Drugs Market Overview
- 15.2. Western Europe Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Isotretinoin Drugs Market
- 16.1. UK Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Isotretinoin Drugs Market
- 17.1. Germany Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Isotretinoin Drugs Market
- 18.1. France Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Isotretinoin Drugs Market
- 19.1. Italy Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Isotretinoin Drugs Market
- 20.1. Spain Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Isotretinoin Drugs Market
- 21.1. Eastern Europe Isotretinoin Drugs Market Overview
- 21.2. Eastern Europe Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Isotretinoin Drugs Market
- 22.1. Russia Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Isotretinoin Drugs Market
- 23.1. North America Isotretinoin Drugs Market Overview
- 23.2. North America Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Isotretinoin Drugs Market
- 24.1. USA Isotretinoin Drugs Market Overview
- 24.2. USA Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Isotretinoin Drugs Market
- 25.1. Canada Isotretinoin Drugs Market Overview
- 25.2. Canada Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Isotretinoin Drugs Market
- 26.1. South America Isotretinoin Drugs Market Overview
- 26.2. South America Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Isotretinoin Drugs Market
- 27.1. Brazil Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Isotretinoin Drugs Market
- 28.1. Middle East Isotretinoin Drugs Market Overview
- 28.2. Middle East Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Isotretinoin Drugs Market
- 29.1. Africa Isotretinoin Drugs Market Overview
- 29.2. Africa Isotretinoin Drugs Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Isotretinoin Drugs Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Isotretinoin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Isotretinoin Drugs Market Competitive Landscape And Company Profiles
- 30.1. Isotretinoin Drugs Market Competitive Landscape
- 30.2. Isotretinoin Drugs Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Isotretinoin Drugs Market Other Major And Innovative Companies
- 31.1. Hetero Drugs Ltd.
- 31.2. Sun Pharmaceuticals Industries Limited
- 31.3. Intas Pharmaceuticals Ltd.
- 31.4. Aurobindo Pharma
- 31.5. Dr. Reddy's Laboratories Ltd.
- 31.6. Cipla Limited
- 31.7. Amneal Pharmaceuticals LLC
- 31.8. Lupin Pharmaceuticals Inc.
- 31.9. Zydus Lifesciences Limited
- 31.10. Glenmark Pharmaceuticals
- 31.11. Alkem Laboratories
- 31.12. Torrent Pharmaceuticals Ltd
- 31.13. Almirall LLC
- 31.14. Alembic Pharmaceuticals Ltd
- 31.15. Ajanta Pharma Ltd.
32. Global Isotretinoin Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Isotretinoin Drugs Market
34. Recent Developments In The Isotretinoin Drugs Market
35. Isotretinoin Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Isotretinoin Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Isotretinoin Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Isotretinoin Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
